U.S. Markets close in 1 hr 40 mins
  • S&P 500

    4,132.06
    -9.53 (-0.23%)
     
  • Dow 30

    33,796.41
    +119.14 (+0.35%)
     
  • Nasdaq

    13,895.35
    -100.75 (-0.72%)
     
  • Russell 2000

    2,256.60
    +27.68 (+1.24%)
     
  • Crude Oil

    63.20
    +3.02 (+5.02%)
     
  • Gold

    1,735.10
    -12.50 (-0.72%)
     
  • Silver

    25.41
    -0.02 (-0.08%)
     
  • EUR/USD

    1.1980
    +0.0026 (+0.2156%)
     
  • 10-Yr Bond

    1.6380
    +0.0150 (+0.92%)
     
  • Vix

    17.09
    +0.44 (+2.64%)
     
  • GBP/USD

    1.3784
    +0.0032 (+0.2302%)
     
  • USD/JPY

    108.9590
    -0.0890 (-0.0816%)
     
  • BTC-USD

    62,361.17
    -891.73 (-1.41%)
     
  • CMC Crypto 200

    1,365.16
    -10.62 (-0.77%)
     
  • FTSE 100

    6,939.58
    +49.09 (+0.71%)
     
  • Nikkei 225

    29,620.99
    -130.62 (-0.44%)
     

Company News for Mar 3, 2021

Zacks Equity Research
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Shares of Kohl’s Corporation KSS gained 0.65% after the company reported fourth-quarter fiscal 2020 earnings of $2.22 per share, surpassing the Zacks Consensus Estimate of $1.04.

  • AutoZone, Inc.’s AZO shares increased 0.9% after the company reported second-quarter fiscal 2021 earnings of $14.93 per share, beating the Zacks Consensus Estimate of $13.07.

  • Shares of TG Therapeutics, Inc. TGTX declined 0.3% after it reported fourth-quarter 2020 loss of $0.71 per share, wider than the Zacks Consensus Estimate of a loss of $0.57.

  • Kontoor Brands, Inc.’s KTB shares jumped 7.7% after the company reported fourth-quarter 2020 earnings of $1.23 per share, beating the Zacks Consensus Estimate of $0.95.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Kohls Corporation (KSS) : Free Stock Analysis Report
 
TG Therapeutics, Inc. (TGTX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research